- « Previous
- Clinical Pharmacology
- Next »
Ziac
Clinical Pharmacology
Ziac
Electrophysiology studies in man have demonstrated that bisoprolol fumarate significantly decreases heart rate, increases sinus node recovery time, prolongs AV node refractory periods, and, with rapid atrial stimulation, prolongs AV nodal conduction.
Hydrochlorothiazide
Acute effects of thiazides are thought to result from a reduction in blood volume and cardiac output, secondary to a natriuretic effect, although a direct vasodilatory mechanism has also been proposed. With chronic administration, plasma volume returns toward normal, but peripheral vascular resistance is decreased.
Thiazides do not affect normal blood pressure. Onset of action occurs within 2 hours of dosing, peak effect is observed at about 4 hours, and activity persists for up to 24 hours.
CLINICAL STUDIES
In controlled clinical trials, bisoprolol fumarate/hydrochlorothiazide 6.25 mg has been shown to reduce systolic and diastolic blood pressure throughout a 24-hour period when administered once daily. The effects on systolic and diastolic blood pressure reduction of the combination of bisoprolol fumarate and hydrochlorothiazide were additive. Further, treatment effects were consistent across age groups ( < 60, ³ 60 years), racial groups (black, nonblack) and gender (male, female).
In two randomized, double-blind, placebo-controlled trials conducted in the U.S., reductions in systolic and diastolic blood pressure and heart rate 24 hours after dosing in patients with mild-to-moderate hypertension are shown in TABLE 1A and TABLE 1B. In both studies mean systolic/diastolic blood pressure and heart rate at baseline were approximately 151/101 mm HG and 77 bpm.
| TABLE 1A Sitting Systolic/Diastolic Pressure (BP) and Heart Rate (HR) | ||
| Study 1 | ||
|---|---|---|
| Mean Decrease (d) After 3-4 Weeks | Placebo | B5/H6.25 mg |
| n= | 75 | 150 |
| Total dBP (mm Hg) | -2.9/-3.9 | -15.8/-12.6 |
| Drug Effecta | -/- | -12.9/-8.7 |
| Total dHR (bpm) | -0.3 | -6.9 |
| Drug Effecta | - | -6.6 |
| a Observed mean change from baseline minus placebo | ||
| TABLE 1B Sitting Systolic/Diastolic Pressure (BP) and Heart Rate (HR) | ||||
| Study 2 | ||||
|---|---|---|---|---|
| Mean Decrease (d) After 3-4 Weeks | Placebo | H6.25 mg | B2.5/H6.25 mg | B10/H6.25 mg |
| n= | 56 | 23 | 28 | 25 |
| Total dBP (mm Hg) | -3.0/-3.7 | -6.6/-5.8 | -14.1/-10.5 | -15.3/-14.3 |
| Drug Effecta | -/- | -3.6/-2.1 | -11.1/-6.8 | -12.3/-10.6 |
| Total dHR (bpm) | -1.6 | -0.8 | -3.7 | -9.8 |
| Drug Effecta | - | +0.8 | -2.1 | -8.2 |
| a Observed mean change from baseline minus placebo. | ||||
Generic Name: Bisoprolol and Hydrochlorothiazide
- « Previous
- Clinical Pharmacology
- Next »
Soy for High Blood Pressure
About 65 million Americans have high blood pressure and more and more are turning to alternative therapies. Here, we look at soy. See more WebMD Videos »
Hypertension
Get tips on handling your hypertension.

